Brady's Healthcare

Bredis Healthcare Inc. is a South Korean startup established in February 2023 by co-CEOs Hyundoo Hwang and Jina Kim. The company focuses on developing solutions for brain disorders, with an initial emphasis on Alzheimer's disease. It provides an integrated platform for the early diagnosis, prognosis, treatment, and management of dementia through ultra-sensitive biomarker detection in bodily fluids and personalized cognitive training programs.

The core of Bredis Healthcare's offering is its proprietary digital ELISA technology, which is reportedly 10,000 times more sensitive than conventional blood tests. This platform is designed to detect key Alzheimer's-related biomarkers, such as P-tau, neurofilament light chain (NFL), and glial fibrillary acidic protein (GFAP), from a simple blood test, even at very low concentrations. The company's AI-driven data analytics technology, which has received patents in Korea, supports the biomarker analysis. The business model involves providing these advanced testing services to university hospitals and research institutes, as well as developing in-vitro diagnostic medical devices for broader commercialization.

Since its founding, the company has achieved several milestones, including winning the D.Day startup pitch competition in June 2023. It secured seed funding from KAIST Venture Investment Holdings and an affiliate of Checkmate Capital Group in May 2023. In August 2023, Bredis Healthcare was awarded a KRW 1.7 billion grant from the South Korean Ministry of SMEs and Startups' Deep Tech TIPS program to accelerate the development and commercialization of its diagnostic platform, with a planned launch by 2025.

Keywords: Alzheimer's diagnosis, neurodegenerative disease, biomarker detection, digital ELISA, blood test diagnostics, cognitive training, in-vitro diagnostic, dementia care, p-tau biomarker, neurofilament light chain, GFAP biomarker, Korean biotech, healthcare technology, medical diagnostics, AI data analytics, personalized medicine, early disease detection, prognosis monitoring, brain disorder solutions, medtech startup